Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
6.82
-0.05 (-0.73%)
At close: Nov 13, 2026, 4:00 PM EST
6.82
0.00 (0.00%)
Pre-market: Nov 16, 2026, 4:15 AM EST
Arvinas Employees
Arvinas had 246 employees as of December 31, 2025. The number of employees decreased by 184 or 42.79% compared to the previous year. That makes Arvinas the 25,315th largest employer in the world and 3,229th in the United States.
Employees
246
Change (1Y)
-184
Growth (1Y)
-42.79%
Revenue / Employee
$1,119,106
Profits / Employee
-$38,618
Market Cap
446.61M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 246 | -184 | -42.79% |
| Dec 31, 2024 | 430 | -15 | -3.37% |
| Dec 31, 2023 | 445 | 30 | 7.23% |
| Dec 31, 2022 | 415 | 135 | 48.21% |
| Dec 31, 2021 | 280 | 101 | 56.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Gyre Therapeutics | 625 |
| Assembly Biosciences | 73 |
| CytomX Therapeutics | 69 |
| Prothena Corporation | 67 |
| Oculis Holding AG | 60 |
| Shattuck Labs | 40 |
| DiaMedica Therapeutics | 35 |
ARVN News
- 4 days ago - Arvinas to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 9 days ago - Arvinas price target lowered to $15 from $16 at BofA - TheFly
- 11 days ago - Arvinas to Present Preliminary Clinical Data from Early Monotherapy Dose Escalation Cohorts in the Phase 1 Trial for ARV-393 (Zaloblideg), a PROTAC BCL6 Degrader, at the 2026 American Society of Hematology (ASH®) Annual Meeting - GlobeNewsWire
- 12 days ago - Arvinas files $400M mixed securities shelf - TheFly
- 12 days ago - Arvinas price target lowered to $13 from $18 at H.C. Wainwright - TheFly
- 12 days ago - Arvinas Earnings Call Transcript: Q3 2026 - Transcripts
- 12 days ago - Arvinas Earnings release: Q3 2026 - Filings
- 12 days ago - Arvinas Quarterly report: Q3 2026 - Filings